No description
-
2015 (v1)PublicationUploaded on: April 14, 2023
-
2016 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2019 (v1)Publication
No description
Uploaded on: March 27, 2023 -
2023 (v1)Publication
No description
Uploaded on: February 11, 2024 -
2022 (v1)Publication
The study of circulating cancer-derived components (circulome) is considered the new frontier of liquid biopsy. Despite the recognized role of circulome biomarkers, their comparative molecular profiling is not yet routine. In advanced breast cancer (BC), approximately 40% of hormone-receptor-positive, HER2-negative BC cases harbor druggable...
Uploaded on: January 31, 2024 -
2020 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2023 (v1)Publication
: Background and purpose: Lung cancer is the leading cause of death in both men and women, constituting a major public health problem worldwide. Non-small-cell lung cancer accounts for 85%-90% of all lung cancers. We propose a compound that successfully fights tumor growth in vivo by targeting the enzyme GARS1. Experimental approach: We present...
Uploaded on: February 13, 2024 -
2023 (v1)Publication
Purpose: In estrogen receptor-positive (ER+) breast cancer (BC), single-nucleotide polymorphisms (SNPs) in the aromatase gene might affect aromatase inhibitors (AIs) metabolism and efficacy. Here, we assessed the impact of SNPs on prognosis and toxicity of patients receiving adjuvant letrozole. Experimental design: We enrolled 886...
Uploaded on: February 14, 2024